Aethlon Medical stock traded up $0.01 during trading hours on Thursday, reaching $0.23. 63,600 shares of the company were exchanged, compared to its average volume of 184,281. The firm has a market capitalization of $4.40 million, a price-to-earnings ratio of -0.68 and a beta of 1.29. The firm has a 50-day moving average price of $0.33. Aethlon Medical has a 12 month low of $0.20 and a 12 month high of $1.74.
Aethlon Medical (NASDAQ:AEMD) last announced its earnings results on Monday, July 1st. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). The business had revenue of $0.08 million during the quarter, compared to analysts’ expectations of $0.08 million. Equities research analysts forecast that Aethlon Medical will post -0.27 earnings per share for the current year.
About Aethlon Medical
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.
Read More: Bear Market – How and Why They Occur
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.